Anticoagulant therapy with ancrod.
Soutar
R L
RL
McMaster University Medical Centre, Hamilton, Ontario.
Ginsberg
J S
JS
D000721:Ancrod / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D000075202:Contraindications; D004341:Drug Evaluation; D004361:Drug Tolerance; D005342:Fibrinolysis / Q000187:drug effects; D005921:Glomerulonephritis / Q000188:drug therapy; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000009:adverse effects; D006801:Humans; D017202:Myocardial Ischemia / Q000188:drug therapy; D013921:Thrombocytopenia / Q000139:chemically induced / Q000188:drug therapy; D013923:Thromboembolism / Q000188:drug therapy
D006493:Heparin; D000721:Ancrod